ATP5PO and type 1 diabetes mellitus: Our results are in line with a small Turkish study, which found no significant difference in the frequency of concurrent thyroid autoantibodies (neither in ATPO nor in ATG) in newly diagnosed T1D children during the first pandemic year (February 2020 - January 2021) in comparison to the previous three years (February 2017 - January 2020) (13).